Editorial: Deciphering the microbiome's role in the progression of interstitial lung diseases

• by Roberto G. Carbone, Anne Marie Russell

• June 1, 2026

Microbiome-innate immune crosstalk in acute exacerbation of idiopathic pulmonary fibrosis: an amplification framework

• by Wanwan Zhang, Jiayang Yi, Zhi Li

• May 1, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min

Sex Disparities May Persist in CF Despite Modulators

Review findings suggested female patients with cystic fibrosis may continue to experience worse pulmonary outcomes despite highly effective modulator therapy

• by Andrea Surnit

• May 22, 2026

• 6 min